Zoetis | ZTS - Selling And Administration Expenses

Stock Price
116.87
Daily Change
0.81 0.70%
Monthly
0.14%
Yearly
-23.85%
Q2 Forecast
119.69

Zoetis reported $619M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Coherus Biosciences USD 15M 6.26M Dec/2025
Dentsply International USD 383M 28M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Henry Schein USD 808M 48M Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Illumina USD 283M 27M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
J&J USD 6.03B 719M Mar/2026
Laboratory Of America USD 538.6M 13.8M Dec/2025
Merck USD 2.85B 215M Dec/2025
Neogen USD 98.5M 9M Dec/2025
Pacira USD 91.87M 70K Dec/2025
Perrigo USD 255.9M 10.2M Dec/2025
Pfizer USD 4.08B 894M Dec/2025
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Sanofi EUR 2.33B 419M Mar/2026
Sanofi EUR 2.75B 455M Dec/2025
Zoetis USD 619M 40M Dec/2025